Antileukotriene Reverts the Early Effects of Inflammatory Response of Distal Parenchyma in Experimental Chronic Allergic Inflammation

Imagem de Miniatura
Arquivos
art_GOBBATO_Antileukotriene_Reverts_the_Early_Effects_of_Inflammatory_Response_2013.PDF (7.06 MB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI PUBLISHING CORPORATION
Autores
FUMAGALLI, Stella Bruna Napolitano
PRADO, Carla Maximo
Citação
BIOMED RESEARCH INTERNATIONAL, article ID 523761, 15p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aims. Compare the effects of montelukast or dexamethasone in distal lung parenchyma and airway walls of guinea pigs (GP) with chronic allergic inflammation. Methods. GP have inhaled ovalbumin (OVA group-2x/week/4weeks). After the 4th inhalation, GP were treated with montelukast or dexamethasone. After 72 hours of the 7th inhalation, GP were anesthetised, and lungs were removed and submitted to histopathological evaluation. Results. Montelukast and dexamethasone treatments reduced the number of eosinophils in airway wall and distal lung parenchyma compared to OVA group (P < 0.05). On distal parenchyma, both treatments were effective in reducing RANTES, NF-kappa B, and fibronectin positive cells compared to OVA group (P < 0.001). Montelukast was more effective in reducing eotaxin positive cells on distal parenchyma compared to dexamethasone treatment (P < 0.001), while there was a more expressive reduction of IGF-I positive cells in OVA-D group (P < 0.001). On airway walls, montelukast and dexamethasone were effective in reducing IGF-I, RANTES, and fibronectin positive cells compared to OVA group (P < 0.05). Dexamethasone was more effective in reducing the number of eotaxin and NF-kappa B positive cells than Montelukast (P < 0.05). Conclusions. In this animal model, both treatments were effective in modulating allergic inflammation and remodeling distal lung parenchyma and airway wall, contributing to a better control of the inflammatory response.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/3930
Referências
  1. Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042
  2. Alam R, 1997, J ALLERGY CLIN IMMUN, V99, P273, DOI 10.1016/S0091-6749(97)70042-3
  3. Angeli P, 2008, AM J PHYSIOL-LUNG C, V294, pL1197, DOI 10.1152/ajplung.00199.2007
  4. Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891
  5. Bjermer L, 2001, RESP MED, V95, P703, DOI 10.1053/rmed.2001.1148
  6. Bonsignore MR, 2008, MED SCI SPORT EXER, V40, P405, DOI [10.1249/MSS.0b013e31815d9670, 10.1249/mss.0b013e31815d9670]
  7. Bousquet J, 2000, RESP MED, V94, pS32, DOI 10.1016/S0954-6111(00)90131-8
  8. Broide DH, 2008, J ALLERGY CLIN IMMUN, V121, P560, DOI 10.1016/j.jaci.2008.01.031
  9. BUCALA R, 1994, MOL MED, V1, P71
  10. BURGESS CA, 1990, J APPL PHYSIOL, V68, P1260
  11. Busse WW, 1998, J ALLERGY CLIN IMMUN, V102, pS17, DOI 10.1016/S0091-6749(98)70002-8
  12. Busse WW, 1998, AM J RESP CRIT CARE, V157, pS210
  13. Charokopos N, 2009, CURR MED CHEM, V16, P867
  14. Diamant Z, 1999, CLIN EXP ALLERGY, V29, P1449
  15. Dolhnikoff M, 2009, J ALLERGY CLIN IMMUN, V123, P1090, DOI 10.1016/j.jaci.2009.02.032
  16. Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003
  17. GABBIANI G, 1992, KIDNEY INT, V41, P530, DOI 10.1038/ki.1992.75
  18. Gayan-Ramirez G, 1999, AM J RESP CRIT CARE, V159, P283
  19. Global Initiative for Asthma, 2009, PUBL WHO, V02-3659
  20. Goleva E, 2007, J ALLERGY CLIN IMMUN, V120, P1065, DOI 10.1016/j.jaci.2007.07.042
  21. Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157
  22. Gualano RC, 2006, PULM PHARMACOL THER, V19, P18, DOI 10.1016/j.pupt.2005.02.009
  23. Gutierrez-Ramos JC, 1999, IMMUNOL TODAY, V20, P500, DOI 10.1016/S0167-5699(99)01522-4
  24. Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108
  25. Hocking DC, 2002, CHEST, V122, p275S, DOI 10.1378/chest.122.6_suppl.275S
  26. Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25
  27. Hoshino M, 1998, CLIN EXP ALLERGY, V28, P568
  28. Jancar S., 2001, IMUNOLOGIA, P11
  29. Jartti T, 2008, EUR J PEDIATR, V167, P731, DOI 10.1007/s00431-007-0644-3
  30. JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
  31. Joos S, 2008, THORAX, V63, P453, DOI 10.1136/thx.2007.081596
  32. Kato J, 2005, CLIN IMMUNOL, V117, P177, DOI 10.1016/j.clim.2005.07.003
  33. Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002
  34. Kelloway Judy S., 1994, Archives of Internal Medicine, V154, P1349, DOI 10.1001/archinte.154.12.1349
  35. KHALIL N, 1991, CIBA F SYMP, V157, P194
  36. Knorr B, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e48
  37. Kondo Naomi, 2006, Allergol Int, V55, P287, DOI 10.2332/allergolint.55.287
  38. Lancas T, 2006, J APPL PHYSIOL, V100, P1610, DOI 10.1152/japplphysiol.00828.2005
  39. Leick-maldonado EA, 2004, CLIN EXP ALLERGY, V34, P145, DOI 10.1111/j.1365-2222.2004.01854.x
  40. Lin CC, 2000, IMMUNOL LETT, V73, P57, DOI 10.1016/S0165-2478(00)00200-5
  41. Liu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060705
  42. Luna L. G., 1986, AFIP MANUAL HISTOLOG
  43. Mattoli S, 1997, BIOCHEM BIOPH RES CO, V236, P299, DOI 10.1006/bbrc.1997.6958
  44. McMillan SJ, 2005, CLIN EXP ALLERGY, V35, P388, DOI 10.1111/j.1365-2222.2005.02193.x
  45. Mechiche H, 2003, CLIN EXP ALLERGY, V33, P887, DOI 10.1046/j.1365-2222.2003.01696.x
  46. Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079
  47. Muz MH, 2006, EXP MOL MED, V38, P109
  48. Nagata M, 2005, INT ARCH ALLERGY IMM, V137, P2, DOI 10.1159/000085424
  49. Nakashima AS, 2008, J APPL PHYSIOL, V104, P1778, DOI 10.1152/japplphysiol.00830.2007
  50. Nam YH, 2012, J INVEST ALLERG CLIN, V22, P20
  51. Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
  52. Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011
  53. Peters-Golden M., 2007, NEW ENGL J MED, V357, P1798
  54. Pizzichini E, 1999, EUR RESPIR J, V14, P12, DOI 10.1034/j.1399-3003.1999.14a04.x
  55. Possa SS, 2012, AM J PHYSIOL-LUNG C, V303, pL939, DOI 10.1152/ajplung.00034.2012
  56. Prado CM, 2005, AM J PHYSIOL-LUNG C, V288, pL741, DOI 10.1152/ajplung.00208.2004
  57. Rajah R., 1995, CYTOKINE GROWTH F R, V6, P273
  58. Rajah R, 1996, AM J PHYSIOL-LUNG C, V271, pL1014
  59. SCHWANDER JC, 1983, ENDOCRINOLOGY, V113, P297
  60. Seco AJ, 2000, RESPIRATION, V67, P559, DOI 10.1159/000067474
  61. SEMINARIO MC, 1994, CURR OPIN IMMUNOL, V6, P860, DOI 10.1016/0952-7915(94)90005-1
  62. Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873
  63. SHEPPARD MN, 1992, THORAX, V47, P1064, DOI 10.1136/thx.47.12.1064
  64. Silverman E. S., 2001, Pharmacogenomics Journal, V1, P27
  65. Singh Shailendra R, 2008, Proc Am Thorac Soc, V5, P127, DOI 10.1513/pats.200706-070VS
  66. Smith LJ, 2001, BIODRUGS, V15, P239, DOI 10.2165/00063030-200115040-00004
  67. Souza FCR, 2013, RESP PHYSIOL NEUROBI, V185, P435, DOI 10.1016/j.resp.2012.08.015
  68. Spoelstra FM, 2001, CLIN EXP ALLERGY, V31, P808, DOI 10.1046/j.1365-2222.2001.01111.x
  69. Starling CM, 2009, RESP PHYSIOL NEUROBI, V165, P185, DOI 10.1016/j.resp.2008.11.011
  70. Stelmach I, 2002, J ALLERGY CLIN IMMUN, V109, P257, DOI 10.1067/mai.2002.121456
  71. TANNER AR, 1979, GUT, V20, P1109, DOI 10.1136/gut.20.12.1109
  72. Terán Luis M, 2006, Gac Med Mex, V142, P139
  73. Teran LM, 2000, IMMUNOL TODAY, V21, P235, DOI 10.1016/S0167-5699(00)01634-0
  74. Tiberio IFLC, 1997, AM J RESP CRIT CARE, V155, P1739
  75. Tokuriki S, 2007, CLIN IMMUNOL, V125, P88, DOI 10.1016/j.clim.2007.05.018
  76. Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
  77. TSURUFUJI S, 1984, J PHARMACOL EXP THER, V229, P237
  78. Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624
  79. VANDERMEER TJ, 1995, J APPL PHYSIOL, V78, P1121
  80. Veraldi KL, 2009, AM J RESP CRIT CARE, V180, P611, DOI 10.1164/rccm.200810-1555OC
  81. World Health Organisation, 2000, WORLD HLTH REP 2000
  82. Wu AY, 2003, CLIN EXP ALLERGY, V33, P359, DOI 10.1046/j.1365-2222.2003.01615.x
  83. Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252
  84. Zar J.H., 1984, BIOSTATISTICAL ANAL

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/20